Secobarbital

CHEMBL447 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
238.3 g/mol
LogP
2.0
Phase
4

A short-acting barbiturate that acts as a powerful sedative and hypnotic by depressing activity throughout the central nervous system. Because of its high potential for dependence and overdose, its medical use today is largely limited to specific clinical settings, including physician-assisted dying where legally permitted.

Masse moléculaire

238,2800 g/mol

LogP

2,00

TPSA

75,30 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O

InChI

InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)

Molecular Formula

C12H18N2O3

HBD / HBA

2 / 3

Liaisons Rotatives

5

Atomes Lourds

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A short-acting barbiturate that acts as a powerful sedative and hypnotic by depressing activity throughout the central nervous system. Because of its high potential for dependence and overdose, its medical use today is largely limited to specific clinical settings, including physician-assisted dying where legally permitted.

Yes, Secobarbital is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL447. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5193. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.